Even with the economy in recession mode, the pharmaceutical sector, with high dividend yields, continues to attract institutional and private investors
PMLiVE archive subscribers only.
The full content of this article is available to PMLiVE archive subscribers. If you have a current subscription, please use the login box to the left. If you would like to find out more about the PMLiVE archive, please
click here.
